Scientists have grown a nugget-sized piece of chicken using a new method that can deliver nutrients and oxygen to artificial tissues, marking a major breakthrough in cultured meat. While labs have been producing lifelike tissues for more than a decade, previous methods only made small, scattered cell balls less than 1 millimeter thick, or about 0.04 inches. It was a challenge to hold the cell groupings together in a way that more closely mimicked the texture of muscle, and the current generation of lab-grown meats are often tiny pieces clumped together around an edible scaffolding. However, a team of researchers in Japan have achieved new lengths, growing a single, square piece of chicken 2.7 inches (7 centimeters) wide and 0.7 inches (2 centimeters) thick with a new lab tool, according to a paper published Wednesday in the journal Trends in Biotechnology. Weighing in at about a third of an ounce, the artificial chicken muscle is a small bite, but is believed to be the world’s largest chunk of lab-grown meat. The scientists developed a bioreactor that mimicked a circulatory system, using 50 hollow fibers acting like veins to distribute nutrients and oxygen to the meat, keeping cells alive and guiding them to grow in the specified directions. The bioreactor delivered nutrients and oxygen through the tissue using tiny, precision-laid hollow fibers, using a method that, for the first time, could sustain growth across relatively long cellular distances. This piece of chicken was not made using food-grade materials, and the scientists have not tasted it. “It’s exciting to discover that these tiny fibers can also effectively help create artificial tissues,” Shoji Takeuchi, a co-author of the study and a professor at the University of Tokyo in Japan, said in a statement. Hollow fibers had previously been used in household water filters and dialysis machines for patients with kidney disease. The new approach, he said, could be a scalable way to produce whole-cut cultured meat, adding that it could yield advancements not just in food production, but also regenerative medicine, drug testing and biohybrid robotics. The new technology could accelerate the commercial viability of cultured meat, but there are further challenges ahead. Replicating the texture and taste of whole-cut meat remains “difficult,” Takeuchi said, adding that larger pieces will also require better oxygen delivery. Additionally, the process of removing tiny hollow fibers that help grow the meat, currently done by researchers manually, needs to be automated, he said, adding that future lab-grown meat will also have to be made with food-grade materials before they can be eaten. Consumers in the United States have mixed attitudes toward cultured meat. About a third say they are not willing to try cultivated chicken, and 40% reject cultivated pork, according to a 2024 poll conducted by Purdue University in Indiana. Ethical and environmental concerns may prompt consumers to opt for plant-based meat substitutes, but cultured meat presents a different hurdle to acceptance partly due to perceived food risks, such as its unnaturalness, unfamiliarity and concerns about whether it is safe or healthy to eat, according to a 2022 study. Currently, there is little cultured meat in the market, but they can be legally sold to consumers in three countries: Singapore, the U.S. and Israel. Only two California companies are authorized to sell cultured meat in the U.S., while Florida and Alabama have banned its sales. In 2013, the world’s first lab-grown burger made from cow stem cells was cooked and publicly tasted in London, to ambivalent reviews.

Nora Aunor, who became one of the biggest stars of Philippine cinema during a career that spanned seven decades, has died. Aunor died Wednesday, according to social media posts from her children. She was 71. No further details on the cause or place of her death were immediately given. Filipina actor Lotlot de León said on Instagram that her mother “touched generations with her unmatched talent, grace, and passion for the craft. Her voice, presence, and artistry shaped a legacy that will never fade.” De León said funeral plans and other details will be shared later. Aunor, born Nora Cabaltera Villamayor to an impoverished family in eastern Camarines Sur province, sold water in a train station in her hometown in her youth. She first gained fame in her teens as a singer in the 1960s before moving on to movies. She amassed more than 200 credits in film and television that included many classics of Philippine cinema, and won dozens of acting awards. Memorable roles included 1976’s “Tatlong Taong Walang Diyos” (“Three Years Without God”), 1984’s “Bulaklak sa City Jail” (“Flowers of the City Jail”) and 1995’s “The Flor Contemplacion Story.” She swept best actress awards in the country for her performance in 1990’s “Andrea, Paano ba ang Maging Isang Ina?” (“Andrea, What is It Like to be a Mother?”) and won best actress at the Asian Film Awards for her portrayal of a midwife in 2012’s “Thy Womb.” Aunor was still acting as recently as last year, starring in the film “Mananambal” (“The Healer”) and appearing on the TV series “Lilet Matias, Attorney-at-Law.” Aunor was named a National Artist for Film and Broadcast Arts — the country’s biggest honor for actors — in 2022. In 2014, then-President Benigno Aquino III had denied her the honor because of a previous drug arrest in the U.S., provoking broad outcry. Aunor’s lawyer said the 2005 arrest at the Los Angeles airport came because of a pipe found in a bag she did not pack, noting she was traveling with four assistants at the time. The charges were dropped in 2007 after she completed a diversion program, her lawyer said in 2014. Aunor was married to actor Christopher de León from 1975 until 1996. She is survived by their children Lotlet, Ian, Matet, Kiko and Kenneth de León.

The World Trade Organization (WTO) warned on Wednesday that the outlook for global trade has “deteriorated sharply” in the wake of U.S. President Donald Trump’s tariffs regime. “The outlook for global trade has deteriorated sharply due to a surge in tariffs and trade policy uncertainty,” the WTO said in its latest “Global Trade Outlook and Statistics” report out Wednesday. Based on the tariffs currently in place, and including a 90-day suspension of “reciprocal tariffs,” the volume of world merchandise trade is now expected to decline by 0.2% in 2025, before posting a “modest” recovery of 2.5% in 2026. The decline is anticipated to be particularly steep in North America, where exports are forecasted to drop by 12.6% this year. The WTO also warned that “severe downside risks exist,” including the application of “reciprocal” tariffs and a broader spillover of policy uncertainty, “which could lead to an even sharper decline of 1.5% in global goods trade,” particularly hurting export-oriented, least-developed countries. The recent tariff disturbances follow a strong year for world trade in 2024, during which merchandise trade grew 2.9% and commercial services trade expanded by 6.8%, the WTO said. The new estimate of a 0.2% decline in world trade for 2025 is nearly three percentage points lower than it would have been under a “low tariff” baseline scenario, the WTO added, and marks a significant reversal from the start of the year when the trade body’s economists expected to see continued trade expansion supported by improving macroeconomic conditions. “Risks to the forecast include the implementation of the currently suspended reciprocal tariffs by the United States, as well as a broader spillover of trade policy uncertainty beyond U.S.-linked trade relationships,” the WTO said. “If enacted, reciprocal tariffs would reduce world merchandise trade growth by an additional 0.6 percentage points, posing particular risks for least-developed countries (LDCs), while a spreading of trade policy uncertainty (TPU) would shave off a further 0.8 percentage points. Taken together, the reciprocal tariffs and spreading TPU would lead to a 1.5% decline in world merchandise trade volume in 2025.” Trump stunned trading partners and global markets in early April, when he announced a raft of “reciprocal” tariffs on imports from more than 180 countries. Beijing was hit the hardest of all, with the U.S. duty on Chinese imports now effectively totaling 145%. China in turn hit back at Washington with retaliatory tariffs of up to 125% on U.S. imports. Widespread market turbulence following the tariffs announcement prompted a temporary climbdown by Trump, with the president last week announcing that the new duties on imports from most trading partners would be reduced to 10% for 90 days in order to allow for trade negotiations with Washington’s counterparts. The WTO said in its Wednesday report that the impact of recent trade policy changes is likely to vary sharply from region to region. In the adjusted forecast, North America now subtracts 1.7 percentage points from global merchandise trade growth in 2025, turning the overall figure negative. Meanwhile, Asia and Europe continue to contribute positively, but less than in the baseline scenario, with Asia’s input halved to 0.6 percentage points. The disruption in U.S.-China trade is expected “to trigger significant trade diversion,” the WTO added, raising concerns among third markets about increased competition from China. “Chinese merchandise exports are projected to rise by 4% to 9% across all regions outside North America as trade is redirected. At the same time, U.S. imports from China are expected to fall sharply in sectors such as textiles, apparel and electrical equipment, creating new export opportunities for other suppliers able to fill the gap,” the trade organization remarked, noting that this could open the door for some least-developed countries to increase their exports to the U.S. market.

California Gov. Gavin Newsom and state Attorney General Rob Bonta sued the Trump administration in federal court Wednesday over President Donald Trump's sweeping tariffs on U.S. trading partners, arguing that it was illegal for Trump to use certain emergency powers to impose them. The lawsuit, filed in U.S. District Court for the Northern District of California, argues that Trump doesn't have the presidential authority to unilaterally impose tariffs using the International Economic Emergency Powers Act because it "violates the separations-of-powers doctrine." "Trump claims this law is the reason he can impose these tariffs, and he is wrong," Bonta said at a news conference alongside Newsom in Stanislaus County, in California's Central Valley. "The truth is the IEEPA does not apply here. Trump has had to resort to creating bogus national emergencies that defy reason." The state asks the court to declare the tariffs void and block their implementation.Announcing the lawsuit on his latest podcast episode, released Wednesday morning, Newsom said Trump doesn't have "the unilateral authority to impose one of the largest tax increases in U.S. history," emphasizing the impact of tariffs in potentially leading to higher prices. Newsom continued, "Impacts of these tariffs are disproportionately being felt here in California, the No. 1 manufacturing state in America, a state that will be significantly impacted by this unilateral decision by the president of the United States.” At the news conference, Newsom, a Democrat, denounced Republicans who control the House and the Senate for not challenging Trump. "Where the hell is Congress? Where the hell is Speaker [Mike] Johnson? Do your job. They’re sitting there passively as this guy wrecks the economy in the United States of America, which has dominated the global economy," he said. Newsom said California will defend people who voted for Trump, who he said didn't follow through on his promises. “I’m here because they’re disproportionately hurt by this, by the guy that’s betrayed them," he said. "Donald Trump is betraying the people of the Central Valley. He is betraying the people that supported him. Donald Trump has turned their back, his back, on his supporters. We will not turn our back on those that supported Donald Trump. We will have their back." Newsom is a potential 2028 Democratic presidential contender and frequent Trump critic. On his recently launched podcast, he has hosted some conservatives as guests, such as Charlie Kirk and Steve Bannon, drawing criticism from fellow Democrats after he seemed to agree with them on some issues, including transgender athletes’ participation in women's sports. Bonta said it is the 14th lawsuit his office has brought against the Trump administration in the last 14 weeks. "The president is exercising authority that he doesn’t have," he said at the news conference. "The president can’t do unlawful things. Really, it's that simple. And he thinks he’s above the law. He’s not. He thinks he can violate the Constitution and the law, and he can’t. And so it’s up to us to hold him accountable to following the law." The lawsuit argues that Trump can't use the International Economic Emergency Powers Act to unilaterally impose tariffs on Mexico, Canada and China or create an across-the-board 10% tariff. Trump has imposed tariffs on most foreign countries, with China facing the largest, 145%, and other nations facing 10% after he backed off last week from implementing higher duties for 90 days. Trump touted the tariffs as he spoke to reporters at the White House on Tuesday, saying: "We're making tremendous amounts of money, taking in billions and billions, hundreds of billions of dollars in tariffs from other countries that, for many, many decades, just ripped off the United States. And it’s time that we not allow that to happen." Asked for comment on the state's lawsuit Wednesday, White House spokesman Kush Desai said in a statement, "Instead of focusing on California’s rampant crime, homelessness, and unaffordability, Gavin Newsom is spending his time trying to block President Trump’s historic efforts to finally address the national emergency of our country’s persistent goods trade deficits." He added, "The entire Trump administration remains committed to addressing this national emergency that’s decimating America’s industries and leaving our workers behind with every tool at our disposal, from tariffs to negotiations.”

President Donald Trump on Wednesday signed an executive order shutting the de minimis trade loophole, effective May 2. Trump in February abruptly ended the de minimis trade exemption, which allows shipments worth less than $800 to enter the U.S. duty-free. The order overwhelmed U.S. Customs and Border Protection employees and caused the U.S. Postal Service to temporarily halt packages from China and Hong Kong. Within days of its announcement, Trump reversed course and delayed the cancellation of the provision. Wednesday’s announcement, which came alongside a set of sweeping new tariffs, gives customs officials, retailers and logistics companies more time to prepare. Goods that qualify under the de minimis exemption will be subject to a duty of either 30% of their value, or $25 per item. That rate will increase to $50 per item on June 1, the White House said. Use of the de minimis provision has exploded in recent years as shoppers flock to Chinese e-commerce companies Temu and Shein, which offer ultra-low-cost apparel, electronics and other items. U.S. Customs and Border Protection has said it processed more than 1.3 billion de minimis shipments in 2024, up from over 1 billion shipments in 2023. Critics of the provision say it provides an unfair advantage to Chinese e-commerce companies and creates an influx of packages that are “subject to minimal documentation and inspection,” raising concerns around counterfeit and unsafe goods. The Trump administration has sought to close the loophole over concerns that it facilitates shipments of fentanyl and other illicit substances on the claims that the packages are less likely to be inspected by customs agents. Temu and Shein have taken steps to grow their operations in the U.S. as the de minimis loophole has come under greater scrutiny. After onboarding sellers with inventory in U.S. warehouses, Temu recently began steering shoppers to those items on its website, allowing it to speed up deliveries. Shein opened distribution centers in states including Illinois and California in 2022, and a supply chain hub in Seattle last year.

A visit from Prince Harry to Ukraine this week brought a soft power sheen to Europe's latest pledge of military aid to Kyiv, even as U.S. envoy Steve Witkoff prepared to meet Russian President Vladimir Putin in Moscow. At a meeting in Brussels, Ukraine's NATO allies pledged an additional $23 billion in financial assistance to Ukrainian President Volodymyr Zelenskyy, who late Thursday accused Russia of systemically recruiting Chinese citizens to fight on the front lines of the war it has been waging against Ukraine for three years. The war has claimed the lives of at least 46,000 Ukrainian troops and wounded or maimed almost 400,000 more, Zelenskyy told NBC News in February. After visiting London from his home in California to appear at his security-related court case against the British government, the Duke of Sussex met Thursday with some of the war's living victims in the western Ukrainian city of Lviv. A spokesperson for Harry told NBC News that the duke, a non-working royal on an unofficial visit, wanted to see the support and rehabilitation services being provided to Ukrainians. On his tour of the Superhumans Center, he was joined by veterans from the Invictus Games Foundation, a wounded veterans charity that he founded having himself served in the British armed forces. Zelenskyy and his military leaders have warned in recent days that Putin's forces are massing on Ukraine's eastern border as they ready a massive spring offensive. The Ukrainian president said Thursday in a post on X that in addition to his earlier claim that more than 150 Chinese nationals are currently fighting for Russia in Ukraine, “it is crystal clear that these are not isolated cases, but rather systematic Russian efforts... within the jurisdiction of China, to recruit citizens of that country.” The Kremlin dismissed the allegations Thursday, Reuters reported, while China has in recent days rejected any suggestion that it supports its citizens taking part in foreign wars. Before Friday's aid announcement, Europe had already pledged $91 billion in military assistance to Kyiv, overtaking Washington’s $64 billion in February, according to the Kiel Institute for the World Economy. U.S. aid has come into question since the change in administrations earlier this year, with President Donald Trump and his administration repeatedly criticizing Europe's leaders for not doing enough to help Kyiv fight a war on their doorstep. “We are already doing more — and we can go even further,” the E.U.’s high representative for foreign affairs and security policy, Kaja Kallas, said in a post on X on Friday. Europe's military support to Ukraine was at the center of discussions in Brussels on Friday as the United Kingdom and Germany hosted a meeting with 50 other countries, before which Zelenskyy said he planned to raise Ukraine's shortage of air defense systems. In recent months, the U.S. and Ukraine have discussed developing the latter's critical mineral deposits together a makeweight for military aid. Anthony Blinken, the former secretary of state under then-President Joe Biden, told CNBC this week that Zelenskyy had initially been the one to propose such an arrangement. Russian Foreign Ministry spokesperson Maria Zakharova responded Friday, referring to Ukraine’s allied nations as “Zelenskyy’s handlers” Friday, and saying that they had “bought him lock, stock and barrel, used him, and now they are wiping their dirty and bloody hands on him.” Ukraine's mineral wealth has formed one part of the Trump administration's interests in the region as it attempts to broker an end to the war. Another has been an effort to reset relations with Moscow. A steady flow of diplomatic activity has continued since U.S. envoys met separately in Saudi Arabia with Russian and Ukrainian counterparts and Putin sent one of his close allies, Kirill Dmitriev, to Washington earlier this month for talks. Dmitriev is the most senior Kremlin official to visit the U.S. since Russia invaded Ukraine. Similarly, Witkoff arrived in St. Petersburg on Friday to meet with Dmitriev, who is also the head of the Russian Direct Investment Fund, in an effort to break the deadlock in ceasefire talks. Kremlin spokesperson Dmitry Peskov confirmed the meeting Friday morning before later telling state media that Witkoff would once again meet with Putin after doing so previously. He added that the meeting would make for a good opportunity to convey Russia's position to Trump.

The war of words — and trade — between Washington and Beijing took a fresh turn Thursday when a Chinese diplomat declared that her compatriots “don’t back down,” sharing a video of Mao Zedong condemning the United States to underscore her point. China, the world’s second-biggest economy and one of the U.S.’ biggest trading partners, has matched President Donald Trump tariff for tariff in recent days. Its latest levies on U.S. goods took effect Thursday, totaling 84%. As other countries scramble to offer Trump concessions in exchange for tariff reductions, China’s more combative approach has drawn the president’s ire. On Wednesday, citing China’s “lack of respect” for global markets, Trump raised U.S. tariffs on Chinese goods to 125%, even as he announced a 90-day pause on higher targeted tariffs on all other U.S. trading partners. China responded Thursday that while it does not want to fight a trade war, it also won’t shy away from one. “We are Chinese. We are not afraid of provocations. We don’t back down,” Mao Ning, spokesperson for the Chinese Foreign Affairs Ministry, said Thursday in a post on X. The post also included archival footage of Mao Zedong, who founded the People’s Republic of China, speaking in 1953 when the U.S. and China were on opposite sides of the Korean War. “As for how long the war should last, I think we shouldn’t decide that,” says the former Chinese leader Mao, who led the country for more than a quarter of a century until his death in 1976. “In the past, it was decided by Truman. In the future, it will be decided by Eisenhower — or whoever the president of the United States may be. In other words, they can fight for as long as they want — until China’s complete victory,” he continues in the video, which is subtitled in Chinese and English. In another apparent reference to Trump’s tariffs, the spokesperson also shared an illustration of a “Make America Great Again” hat — which is made in countries such as China, Vietnam and Bangladesh — bearing a “Made in China” label and sitting above a $50 price tag crossed out and replaced with $77. A hashtag about the Mao Zedong post was trending Thursday on Weibo, a popular Chinese social media platform. “We shouldn’t hold on to any illusion that America will go easy on China,” one user wrote. “Let Trump make the call — however long they want to fight, we’ll fight.” The Chinese Commerce Ministry did not say whether it would further raise tariffs on U.S. goods in response to Trump’s latest increase. The door to talks “is always open,” a spokesperson said Thursday, “but any dialogue must be based on mutual respect and conducted on equal footing.” Underlying such comments is China’s history of exploitation by Western nations, memories of which remain searing even as China has leveraged globalization to become the world’s largest trading nation in goods. Even though U.S. and Chinese tariffs are already at “trade-prohibitive” levels, Trump’s public calls to negotiate are unlikely to work with China, said Rick Waters, a former State Department diplomat who is now the Singapore-based director of Carnegie China. “The Chinese are proud. They have a history of humiliation at the hands of foreign powers,” he said. “And I think those types of tactics play into their defensive instincts.” The Foreign Ministry’s office in Hong Kong, a former British colony whose 1997 return to Chinese rule marked the end of what is referred to in China as a “century of humiliation,” said Trump’s actions “won’t make America great again — they’ll only turn the U.S. into a 21st-century barbarian.” “Those who try to strong-arm the world with tariffs and expect countries to call and admit defeat should never count on getting a call from China,” it said. Waters said that while he thinks Trump is “sincere in a desire to explore some kind of a deal with the Chinese,” such a deal may be a long way off. “I think until the two sides feel they have to come to the table, they’re going to let the other stew in their juices,” he said.

China’s official Xinhua news agency said Wednesday the fire started at 9 p.m. local time (9 a.m. ET) Tuesday in Chengde city in Hebei province. Six hours later, 20 people were confirmed dead. State broadcaster CCTV said 19 others, who were uninjured, have been transferred to a hospital for observation. Officials are investigating the cause of the fire. State media said a “relevant” person in charge of the facility has been taken in by police, without giving any details.In January, a fire at a food market in the Hebei city of Zhangjiakou killed eight people and injured 15 others.

Global drugmakers’ stocks dropped across the board after U.S. President Donald Trump reiterated plans for a “major” tariff on pharmaceutical imports, threatening an interwoven global supply chain, and as his country-specific reciprocal tariffs took effect, leading to more pain in global markets. Pharmaceutical imports were initially exempt from Trump’s first set of reciprocal tariffs last week — but his administration has since indicated that levies on the sector, which in the past has been excluded from such actions, are coming. The U.S. president has said the tariffs will incentivize drug companies to move operations to the United States. However, analysts and companies have raised concerns about the difficulty in setting up manufacturing in the country. Shares of major U.S. drugmakers Amgen, AbbVie, Pfizer, Merck and Eli Lilly fell between 3% and 6% in premarket trading. In Europe, a basket of healthcare stocks fell 5% to its lowest since October 2022, leading losses among sectoral indexes on the region-wide STOXX 600, which was down 3.3% at 1013 GMT. The index was heading for its biggest one-day drop since March 2020. Trump had also threatened the duties on Friday after his first set of “reciprocal” tariffs exempted pharma products. Trump has not said when and by how much he plans to raise levies on pharma imports. “While the details are scant, we are strongly opposed to tariffs on any pharmaceuticals — these will likely do little to shift manufacturing back to the U.S.,” said BMO Capital Markets analyst Evan Seigerman. “Given the complexity of the pharma supply chain, we do not expect the industry to make any major changes. These current tariffs are being pursued under emergency powers, which at worse will last until the end of the current administration and could end sooner with an act of Congress.” Seigerman also pointed to concerns over recent layoffs at the U.S. Food and Drug Administration, saying the worries were now compounded by the “real talk” of pharma tariffs. Europe and the U.S. have interconnected supply chains for medicines. The United States depends on medicines partly produced in Europe that bring in hundreds of billions of dollars in revenue. Bernstein analyst Courtney Breen wrote in a note that her worst-case scenario assumes tariffs could be steep, leading to about $53 billion in additional costs paid for pharmaceutical imports. If companies did choose to bring new manufacturing to the United States, Breen expects additional spend of $2 billion for each new “green field” site and a five-year runway to production. EU medical and pharmaceutical product exports to the U.S. totaled about 90 billion euros ($97 billion) in 2023, according to latest Eurostat data. Shares of AstraZeneca, GSK, Roche , Sanofi and Novartis fell between 5% and 6.5% in Europe. Meanwhile, Indian pharmaceutical stocks .NIPHARM closed nearly 2% lower, dragging down the benchmark Nifty 50 by 0.6%. IPCA Laboratories, Glenmark Pharma and Biocon were the top losers by percentage on the pharma index in Mumbai, ending the trading session between 4% and 5.5% lower. India’s pharma exports to the U.S. mostly comprise generics, or cheaper versions of popular drugs. The United States accounts for a third of India’s overall pharma exports.

President Donald Trump’s unprecedented tariffs on global imports into the United States took effect Wednesday, reshuffling a global economic order that has largely stood for generations and prompting new retaliations from China and Europe. Now, consumers and investors alike will begin to gauge the actual impact on the U.S. economy as the cost of the import taxes starts to flow through supply chains and into businesses and household budgets. The most immediate response from investors came in the market for government bonds. Contrary to the goals of the Trump administration, U.S. borrowing costs began to climb immediately after the tariffs came into effect overnight — an unexpected move that, combined with falling stock prices, caused some analysts to raise the prospect of broader financial instability. In a post on X, former Treasury Secretary Lawrence Summers said development represented a "highly unusual pattern" that suggests "a generalized aversion to US assets in global financial markets. "We are being treated by global financial markets like a problematic emerging market," he wrote. Meanwhile, Walmart and Delta Air Lines both withdrew earnings guidance Wednesday morning based on the uncertainty Trump's scheme has generated, while JPMorgan Chase CEO said an interview that a recession in the U.S. was now likely. The average tariff faced by the dozens of nations Trump targeted is 29%, with many as high as 40%. The White House has posted the full list on its website. Chinese imports will carry a cumulative rate of as much as 104% because of new tariffs Trump imposed this year, on top of levies he had already enacted during his first term. In response, China announced Wednesday morning it was raising retaliatory duties on imports from the U.S. from 34% to 84%, while the EU agreed to slap duties of as much as 25% on U.S. imports starting next week.